Loading...
Whole Tumor Antigen Vaccines: Where Are We?
With its vast amount of uncharacterized and characterized T cell epitopes available for activating CD4(+) T helper and CD8(+) cytotoxic lymphocytes simultaneously, whole tumor antigen represents an attractive alternative source of antigens as compared to tumor-derived peptides and full-length recomb...
Na minha lista:
| Udgivet i: | Vaccines (Basel) |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4494356/ https://ncbi.nlm.nih.gov/pubmed/26343191 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines3020344 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|